ClinicalTrials.gov
public full text
Public Domain
Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis
The aim of this study was to examine the effect of zoledronic acid and alendronate on bone metabolism as measured by biomarkers in postmenopausal women with osteoporosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)#874694
- Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery#1093465
- Characteristics of Marrow Fatty Cells in the Ageing of Bone and Joints, Osteoarthritis and Osteoporosis#346826
- Obesity, Inflammation and Oxidative Stress#1111404
- Novel therapeutic approaches for inflammation-induced bone loss : evaluation of the anti-inflammatory effect of Anti-ATX, curcumin and amaranth in a murine model of rheumatoid arthritis#388187
Record · ID 1030042
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive